U.S. drug regulator issues import alert at Dabur India's plant
U.S. drug regulator issues import alert at Dabur India's plant BENGALURU, June 11 (Reuters) - The U.S. Food and Drug Administration has issued an import alert for drugs manufactured at one of Dabur India's DABU.NS plants following an inspection, the consumer goods company said on Thursday.
(Reporting by Nishit Navin; Editing by Shailesh Kuber)
Recent news on Dabur India
See all newsBrief: Dabur Says India Markets Regulator SEBI Has Issued An Administrative Warning Letter To Co
Dabur India falls on lower-than-expected quarterly margin, long-term CEO resignation
Dabur's global CEO resigns, India boss joins board (updated)
Brief: Dabur Says Mohit Malhotra Resigns As Global CEO And Whole-Time Director Effective November 13, 2026
Dabur India's global CEO Mohit Malhotra resigns